Global Longlife Hospital And Research Ltd (BSE: 543520) is an Ahmedabad, Gujarat-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹14 Cr, it ranks #4,618 by market cap among the 6,197 Indian listed companies on FinBizNet, and #42 of 46 in Hospitals and Healthcare Centers. At ₹13.43 (as of 16 Nov 2026), the share price is 47.5% below its 52-week high of ₹25.60 and 49.2% above its 52-week low of ₹9.00. The share price is down 44.7% over one year and up 11.1% over three months.
| Current Price | ₹13.43 |
|---|---|
| Market Cap | ₹14 Cr |
| BSE Code | 543520 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -6.80% |
| Return on Assets | -2.45% |
| 52-Week Range | ₹9.00 – ₹25.60 |
| 1-Year Price Change | -44.7% |
| 3-Month Price Change | +11.1% |
| Beta (1Y) | 0.04 |
| Headquarters | Ahmedabad, Gujarat |
| Website | globalhospital.co.in |
Delivery averaged 87.5% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. The company offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. It also provides radiology services comprising mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, such as microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services that include dialysis, pharmacy, ambulance, dietary,
1. Healthcare Facilities & Services-This segment engages in the multispecialty hospital business.
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Global Longlife Hospital And Research Ltd | ₹14 Cr | n/m | -6.80% | — | -44.7% |
Listed by market capitalisation. Ratios are shown for context only.
Global Longlife Hospital And Research Ltd is trading at ₹13.43, with a market capitalisation of ₹14 Cr.
Global Longlife Hospital And Research Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Global Longlife Hospital And Research Ltd has a return on equity of -6.80%.
Global Longlife Hospital And Research Ltd is listed on the BSE under the scrip code 543520.
Global Longlife Hospital And Research Ltd's share price is down 44.7% over one year and up 11.1% over three months. Its 52-week range is ₹9.00 to ₹25.60.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.